VFA
IDXX icon

Valeo Financial Advisors’s Idexx Laboratories IDXX Stock Holding History

Valeo Financial Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202K Buy
383
+23
+6% +$12.9K ﹤0.01% 764
2026
Q1 		$202K Sell
360
-206
-36% -$132K ﹤0.01% 689
2025
Q4 		$383K Buy
566
+137
+32% +$93.3K 0.01% 539
2025
Q3 		$274K Buy
429
+9
+2% +$5.46K 0.01% 641
2025
Q2 		$225K Buy
+420
New +$201K 0.01% 672
2024
Q3 		– Sell
-468
Closed -$228K – 720
2024
Q2 		$228K Buy
468
+35
+8% +$17.6K 0.01% 573
2024
Q1 		$214K Hold
433
– – 0.01% 592
2023
Q4 		$240K Sell
433
-499
-54% -$234K 0.01% 557
2023
Q3 		$408K Sell
932
-135
-13% -$67.3K 0.02% 382
2023
Q2 		$536K Buy
1,067
+14
+1% +$6.71K 0.02% 302
2023
Q1 		$527K Buy
1,053
+209
+25% +$100K 0.03% 325
2022
Q4 		$344K Buy
844
+162
+24% +$62.9K 0.02% 352
2022
Q3 		$222K Sell
682
-5
-0.7% -$1.84K 0.01% 422
2022
Q2 		$241K Sell
687
-23
-3% -$9.38K 0.02% 404
2022
Q1 		$388K Buy
710
+33
+5% +$17.4K 0.02% 384
2021
Q4 		$446K Buy
677
+60
+10% +$37.7K 0.02% 331
2021
Q3 		$384K Buy
617
+15
+2% +$10.1K 0.02% 352
2021
Q2 		$380K Sell
602
-70
-10% -$38.7K 0.02% 309
2021
Q1 		$329K Buy
672
+120
+22% +$60.1K 0.02% 339
2020
Q4 		$276K Hold
552
– – 0.01% 355
2020
Q3 		$217K Sell
552
-25
-4% -$9.24K 0.02% 309
2020
Q2 		$191K Buy
577
+3
+0.5% +$869 0.02% 329
2020
Q1 		$148K Buy
574
+4
+0.7% +$1.04K 0.02% 345
2019
Q4 		$149K Buy
570
+3
+0.5% +$791 0.01% 379
2019
Q3 		$154K Hold
567
– – 0.02% 343
2019
Q2 		$156K Hold
567
– – 0.02% 340
2019
Q1 		$127K Buy
567
+5
+0.9% +$1.03K 0.02% 365
2018
Q4 		$105K Buy
562
+6
+1% +$1.23K 0.01% 370
2018
Q3 		$118K Hold
556
– – 0.02% 365
2018
Q2 		$134K Buy
+556
New +$115K 0.02% 352

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Valeo Financial Advisors's IDXX Position: Q2 2026 in Review

Valeo Financial Advisors increased its Idexx Laboratories (IDXX) stake by 6.4% in Q2 2026, buying an estimated $12.9K and bringing the position to 383 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #764.

Valeo Financial Advisors first reported a position in IDXX in Q2 2018 and has held it in 30 quarters since. The position peaked at $536K in Q2 2023. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Valeo Financial Advisors held 383 shares of Idexx Laboratories worth $202K as of Q2 2026.
  • Valeo Financial Advisors bought 23 Idexx Laboratories shares in Q2 2026, an estimated $12.9K.
  • Idexx Laboratories made up ﹤0.01% of Valeo Financial Advisors's portfolio in Q2 2026, its #764 holding.
  • Valeo Financial Advisors first reported a position in Idexx Laboratories in Q2 2018 and has held it in 30 quarters since.
  • Valeo Financial Advisors's Idexx Laboratories position peaked at $536K in Q2 2023.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Valeo Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.